ROCHESTER, NY, July 16, 2012 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading distributor of professional grade handheld test and measurement instruments and accredited provider of calibration, repair and other measurement services, announced today that it has acquired Anacor Compliance Services, Inc. (“Anacor”), a nationally recognized and respected provider of specialized analytical, calibration, compliance and validation services to the life sciences sector including the biotechnology, medical device, and pharmaceutical industries.
Headquartered in Furlong, Pennsylvania, Anacor specializes in process validation and compliance qualification with protocol development and execution, as well as final qualification documents. In addition, Anacor provides software and network validation, air sampler, particle counter and pipette calibration along with GC, HPLC and UPLC qualification services and temperature mapping validation services.
Anacor has achieved ISO9001:2008 certification in five essential compliance service components for businesses operating within the Life Sciences Service Sector. Anacor’s certification scope includes Calibration Services, Analytical Instrument Qualification Services, Equipment and Process Validation Services, Calibration Laboratory Services, and Customer Asset Management Services.
With over 40 years combined experience, Anacor was founded in 2008 by Reese Barnum and Michael Branvold, who have joined Transcat together with Anacor’s 23 employees.
Charles P. Hadeed, President and CEO of Transcat, commented, “Consistent with our growth strategy, this acquisition provides for an expanded suite of quality based services to our targeted life sciences industry customer base. We believe this addition capitalizes on the strength of our infrastructure and reputation for quality, service and integrity.”
The terms of the transaction were not disclosed.
ABOUT TRANSCAT
Transcat, Inc. is a leading distributor of professional grade handheld test and measurement instruments and accredited provider of calibration, repair and other measurement services primarily for the pharmaceutical and FDA-regulated, industrial manufacturing, energy and utilities, chemical manufacturing and other industries. Through its distribution products segment, Transcat markets and distributes national and proprietary brand instruments to nearly 15,000 customers. The Company offers access to more than 25,000 test and measurement instruments. Transcat delivers precise, reliable, fast calibration, and repair services across the United States, Canada and Puerto Rico through its 17 strategically located Calibration Centers of Excellence. The breadth and depth of parameters covered by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be among the best in the industry.
Transcat’s growth strategy is to expand both its distribution products and calibration services in markets that value product breadth and availability and rely on accredited calibration services to maintain the integrity of their processes.
More information about Transcat can be found on its website at: transcat.com
Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as “expects,” “estimates,” “projects,” “anticipates,” “believes,” “could,” and other similar words. All statements addressing operating performance, events, or developments that Transcat, Inc. expects or anticipates will occur in the future, including but not limited to statements relating to anticipated revenue, profit margins, sales operations, its strategy to build its sales representative channel, customer preferences and changes in market conditions in the industries in which Transcat operates are forward-looking statements. Because they are forward-looking, they should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Transcat’s Annual and Quarterly Reports filed with the Securities and Exchange Commission, including under the heading entitled “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of the Company’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company’s forward-looking statements. Except as required by law, the Company disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release.
